Filing Details

Accession Number:
0001225208-17-013770
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-08-11 12:19:58
Reporting Period:
2017-08-10
Filing Date:
2017-08-11
Accepted Time:
2017-08-11 12:19:58
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
9892 Bard C R Inc BCR Surgical & Medical Instruments & Apparatus (3841) 221454160
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1580664 P John Groetelaars C/o C. R. Bard, Inc.
730 Central Avenue
Murray Hill NJ 07974
Group President No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2017-08-10 12,482 $136.37 31,445 No 4 M Direct
Common Stock Acquisiton 2017-08-10 8,608 $97.69 40,053 No 4 M Direct
Common Stock Acquisiton 2017-08-10 2,597 $84.58 42,650 No 4 M Direct
Common Stock Disposition 2017-08-10 23,687 $318.73 18,963 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Option (Right to Buy) Disposition 2017-08-10 12,482 $0.00 12,482 $136.37
Common Stock Option (Right to Buy) Disposition 2017-08-10 8,608 $0.00 8,608 $97.69
Common Stock Option (Right to Buy) Disposition 2017-08-10 2,597 $0.00 2,597 $84.58
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
4,161 2023-12-11 No 4 M Direct
0 2022-12-12 No 4 M Direct
0 2021-12-14 No 4 M Direct
Footnotes
  1. Represents the weighted average sales price for price increments ranging from $318.52 to $318.91. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported on this Form 4.
  2. Options granted under 2012 Long Term Incentive Plan of C. R. Bard, Inc. (as Amended and Restated).
  3. Of this option grant 12,482 options vested and the remaining options vest on December 11, 2017.
  4. Options fully vested and are currently exercisable.
  5. Options granted under 2003 Long Term Incentive Plan of C. R. Bard, Inc. (as Amended and Restated).